1.Lamagni TL, et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. Journal of Clinical Microbiology 2008; 46: 2359–2367.
2.Carapetis J, et al. Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clinical Infectious Diseases 1995; 21: 1220–1227.
3.Steer AC, Danchin MH, Carapetis JR. Group A streptococcal infections in children. Journal of Paediatric Child Health 2007; 43: 203–213.
4.Davies HD, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. New England Journal of Medicine 1996; 335: 547–554.
5.O'Grady KA, et al. The epidemiology of invasive group A streptococcal disease in Victoria, Australia. Medical Journal of Australia 2007; 186: 565–569.
6.Rogers S, et al. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections. Journal of Infectious Diseases 2007; 195: 1625–1633.
7.O'Brien KL, et al. Epidemiology of invasive group A streptococcus disease in the United States, 1995–1999. Clinical Infectious Diseases 2002; 35: 268–276.
8.Givner LB. Invasive disease due to group A beta-hemolytic streptococci: continued occurrence in children in North Carolina. Southern Medical Journal 1998; 91: 333–337.
9.Ben-Abraham R, et al. Invasive group A streptococcal infections in a large tertiary center: epidemiology, characteristics and outcome. Infection 2002; 30: 81–85.
10.Tyrrell GJ, et al. Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). Journal of Clinical Microbiology 2005; 43: 1678–1683.
11.Lamagni TL, et al. Severe Streptococcus pyogenes infections, United Kingdom, 2003–2004. Emerging Infectious Diseases 2008; 14: 202–209.
12.Delvecchio A, et al. Streptococcus pyogenes prtFII, but not sfbI, sfbII or fbp54, is represented more frequently among invasive-disease isolates of tropical Australia. Epidemiology and Infection 2002; 128: 391–396.
13.Carapetis JR, et al. Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection. Epidemiology and Infection 1999; 122: 59–65.
14.Norton R, et al. Invasive group A streptococcal disease in North Queensland (1996–2001). Indian Journal of Medical Research 2004; 119 (Suppl.): 148–151.
15.Breiman RF, et al. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. Journal of the American Medical Association 1993; 269: 390–391.
16.Stanley J, et al. High-resolution genotyping elucidates the epidemiology of group A streptococcus outbreaks. Journal of Infectious Diseases 1996; 174: 500–506.
17.Laupland KB, et al. Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region. Clinical Microbiology and Infection 2006; 12: 224–230.
18.Moses AE, et al. Invasive group a streptococcal infections, Israel. Emerging Infectious Diseases 2002; 8: 421–426.
19.Laupland KB, et al. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 2000; 105: E60.
20.O'Loughlin RE, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clinical Infectious Diseases 2007; 45: 853–862.
21.Duff BA, et al. Invasive group A streptococcal disease in children. Clinical Pediatrics 1999; 38: 417–423.
22.Arnholm B, Lundqvist A, Stromberg A. High-dose immunoglobulin – life-saving in invasive group A streptococcal infection. Report of eleven cases with only one fatality. Lakartidningen 2004; 101: 2642–2644.
23.American Academy of Pediatrics. Committee on Infectious Diseases. Severe invasive group A streptococcal infections: a subject review. Pediatrics 1998; 101: 136–140.
24.Burnett AM, Domachowske JB. Therapeutic considerations for children with invasive group a streptococcal infections: a case series report and review of the literature. Clinical Pediatrics 2007; 46: 550–555.
25.Mulla ZD, Leaverton PE, Wiersma ST. Invasive group A streptococcal infections in Florida. Southern Medical Journal 2003; 96: 968–973.
26.Tyrrell GJ, et al. Varicella-associated invasive group A streptococcal disease in Alberta, Canada – 2000–2002. Clinical Infectious Diseases 2005; 40: 1055–1057.
27.Ciftci E, et al. Invasive group A streptococcal infections in children: an emerging infectious disease in Turkey. Annals of Tropical Paediatrics 2004; 24: 365–366.
28.Patel RA, Binns HJ, Shulman ST. Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era. Journal of Pediatrics 2004; 144: 68–74.
29.Nuwayhid ZB, Aronoff DM, Mulla ZD. Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis. Annals of Epidemiology 2007; 17: 878–881.
30.Bryant AE, et al. Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes. Journal of Infectious Diseases 2006; 193: 1685–1692.
31.Musser JM, et al. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proceedings of the National Academy of Sciences USA 1991; 88: 2668–2672.